Fifth disease
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for Fifth disease | |
|
Articles | |
|---|---|
|
Most recent articles on Fifth disease Most cited articles on Fifth disease | |
|
Media | |
|
Powerpoint slides on Fifth disease | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Fifth disease at Clinical Trials.gov Trial results on Fifth disease Clinical Trials on Fifth disease at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Fifth disease NICE Guidance on Fifth disease
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Fifth disease Discussion groups on Fifth disease Patient Handouts on Fifth disease Directions to Hospitals Treating Fifth disease Risk calculators and risk factors for Fifth disease
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Fifth disease | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Fifth disease is also referred to as erythema infectiosum (meaning infectious redness) and as Human Parvovirus B19 Infection, Slapped cheek syndrome, Slapcheek, Slap face or Slapped face. It is a mild rash illness that occurs most commonly in children. The name "fifth disease" derives from its historical classification as the fifth of the classical childhood skin rashes or exanthems. In 1975, the cause of Fifth disease was discovered to be parvovirus B19.
References
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/parvo_b19.htm
http://www.cdc.gov/ncidod/diseases/submenus/sub_parvovirus.htm
Epidemiology and Demographics
Any age may be affected although it is most common in children aged five to fifteen years. By the time adulthood is reached about half the population will have become immune following infection at some time in their past. Outbreaks can arise especially in nurseries and schools.
In a household, as many as 50% of susceptible persons exposed to a family member who has fifth disease may become infected. During school outbreaks, 10% to 60% of students may get fifth disease.
During outbreaks of fifth disease, about 20% of adults and children who are infected with parvovirus B19 do not develop any symptoms. Furthermore, other persons infected with the virus will have a non-specific illness that is not characteristic of fifth disease. Persons infected with the virus, however, do develop lasting immunity that protects them against infection in the future.
References
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/parvo_b19.htm
Pathophysiology & Etiology
Fifth disease is caused by infection with human parvovirus B19. This virus infects only humans. Pet dogs or cats may be immunized against "parvovirus," but these are animal parvoviruses that do not infect humans. Therefore, a child cannot "catch" parvovirus from a pet dog or cat, and a pet cat or dog cannot catch human parvovirus B19 from an ill child.
A person infected with parvovirus B19 is contagious during the early part of the illness, before the rash appears. By the time a child has the characteristic "slapped cheek" rash of fifth disease, for example, he or she is probably no longer contagious and may return to school or child care center. This contagious period is different than that for many other rash illnesses, such as measles, for which the child is contagious while he or she has the rash.
Parvovirus B19 has been found in the respiratory secretions (e.g., saliva, sputum, or nasal mucus) of infected persons before the onset of rash, when they appear to "just have a cold." The virus is probably spread from person to person by direct contact with those secretions, such as sharing drinking cups or utensils. A susceptible person usually becomes ill 4 to 14 days after being infected with the virus, but may become ill for as long as 20 days after infection.
References
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/parvo_b19.htm
Diagnosis
A physician can often diagnose fifth disease by seeing the typical rash during a physical examination. In cases in which it is important to confirm the diagnosis, a blood test may be done to look for antibodies to parvovirus. Antibodies are proteins produced by the immune system in response to parvovirus B19 and other germs. If immunoglobulin M (IgM) antibody to parvovirus B19 is detected, the test result suggests that the person has had a recent infection.
References
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/parvo_b19.htm
History and Symptoms
The most common illness caused by parvovirus B19 infection is "fifth disease," a mild rash illness that occurs most often in children. The ill child typically has a "slapped-cheek" rash on the face and a lacy red rash on the trunk and limbs. Occasionally, the rash may itch. The child is usually not very ill, and the rash resolves in 7 to 10 days. Once a child recovers from parvovirus infection, he or she develops lasting immunity, which means that the child is protected against future infection.
References
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/B19&preg.htm
Physical Examination
Skin
Risk Stratification and Prognosis
Fifth disease is usually a mild illness that resolves on its own among children and adults who are otherwise healthy. Joint pain and swelling in adults usually resolve without long-term disability.
Parvovirus B19 infection may cause a serious illness in persons with sickle-cell disease or similar types of chronic hemolytic anemia. In such persons, parvovirus B19 can cause an acute, severe anemia. The ill person may be pale, weak, and tired, and should see his or her physician for treatment. (The typical rash of fifth disease is rarely seen in these persons.) Once the infection is controlled, the anemia resolves. Furthermore, persons who have problems with their immune systems may also develop a chronic anemia with parvovirus B19 infection that requires medical treatment. People who have leukemia or cancer, who are born with immune deficiencies, who have received an organ transplant, or who have human immunodeficiency virus (HIV) infection are at risk for serious illness due to parvovirus B19 infection.
Occasionally, serious complications may develop from parvovirus B19 infection during pregnancy. Infection in the first trimester has been linked to hydrops fetalis, causing spontaneous abortion.
For details on pregnancy complications, please see the CDC information sheet entitled, "Parvovirus B19 Infection and Pregnancy."
I've recently been exposed to a child with fifth disease. How will this affect my pregnancy?
Usually, there is no serious complication for a pregnant woman or her baby because of exposure to a person with fifth disease. About 50% of women are already immune to parvovirus B19, and these women and their babies are protected from infection and illness. Even if a woman is susceptible and gets infected with parvovirus B19, she usually experiences only a mild illness. Likewise, her unborn baby usually does not have any problems attributable to parvovirus B19 infection.
Sometimes, however, parvovirus B19 infection will cause the unborn baby to have severe anemia and the woman may have a miscarriage. This occurs in less than 5% of all pregnant women who are infected with parvovirus B19 and occurs more commonly during the first half of pregnancy. There is no evidence that parvovirus B19 infection causes birth defects or mental retardation.
References
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/parvo_b19.htm
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/B19&preg.htm
Treatment
Treatment of symptoms such as fever, pain, or itching is usually all that is needed for fifth disease. Adults with joint pain and swelling may need to rest, restrict their activities, and take medicines such as aspirin or ibuprofen to relieve symptoms. The few people who have severe anemia caused by parvovirus B19 infection may need to be hospitalized and receive blood transfusions. Persons with immune problems may need special medical care, including treatment with immune globulin (antibodies), to help their bodies get rid of the infection.
If I'm infected, what do I need to do about my pregnancy?
There is no universally recommended approach to monitor a pregnant woman who has a documented parvovirus B19 infection. Some physicians treat a parvovirus B19 infection in a pregnant woman as a low-risk condition and continue to provide routine prenatal care. Other physicians may increase the frequency of doctor visits and perform blood tests and ultrasound examinations to monitor the health of the unborn baby. The benefit of these tests in this situation, however, is not clear. If the unborn baby appears to be ill, there are special diagnostic and treatment options available, and your obstetrician will discuss these options with you and their potential benefits and risks.
Pharmacotherapy
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/parvo_b19.htm
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/B19&preg.htm
Primary Prevention
There is no vaccine or medicine that prevents parvovirus B19 infection. Frequent handwashing is recommended as a practical and probably effective method to decrease the chance of becoming infected. Excluding persons with fifth disease from work, child care centers, or schools is not likely to prevent the spread of the virus, since people are contagious before they develop the rash.
Is there a way I can keep from being infected with parvovirus B19 during my pregnancy?
There is no vaccine or medicine that prevents parvovirus B19 infection. Frequent hand washing is recommended as a practical and probably effective method to reduce the spread of parvovirus. Excluding persons with fifth disease from work, child care centers, schools, or other settings is not likely to prevent the spread of parvovirus B19, since ill persons are contagious before they develop the characteristic rash.
CDC does not recommend that pregnant women should routinely be excluded from a workplace where a fifth disease outbreak is occurring, because of the problems noted above. Rather, CDC considers that the decision to stay away from a workplace where there are cases of fifth disease is an personal decision for a woman to make, after discussions with her family, physician, and employer.
References
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/parvo_b19.htm
http://www.cdc.gov/ncidod/dvrd/revb/respiratory/B19&preg.htm
References
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.
List of contributors:
- Pilar Almonacid
External links
Exanthema | |
|---|---|
| Viral | Measles (1st disease) - Rubella (3rd disease) - Duke's disease (4th disease) - Slap cheek (5th disease) - Roseola (6th disease) |
| Bacterial | Scarlet fever (2nd disease) |
da:Lussingesyge de:Ringelrötelnnl:Vijfde ziekteno:Femte barnesykdomfi:Parvorokko
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
